Cutting through the hype: Optimising AI in clinical data
Artificial intelligence (AI) has become one of the most talked-about technologies of our time, but when it comes to complex…
All articles by Alexander Love
Alexander Love
-
-
Podcast: Reflecting on 2025 trend predictions
This finale in the first Zelta Podcast series follows up on an article published on 8 January on Pharmaceutical-Technology.com and…
-
Solving global CDMO challenges: Indena and TCG GreenChem’s strategic-alliance
Contract development and manufacturing organisations (CDMOs) are facing mounting pressures to streamline production processes while adhering to increasingly stringent quality…
-
Podcast: How RWD Furthers Understanding of Pregnancy
This podcast explores how real-world data (RWD) fills gaps in understanding maternal and infant health, especially since pregnant individual often…
-
Comparator sourcing: Essential information from Oximio – podcast
This series explores the innovations, logistics and behind-the-scenes operations that keep clinical research moving with expert insight from Oximio. In…
-
Podcast: Migration of clinical studies
Migrating clinical studies to a new platform requires careful planning and is the focus of episode four in the Zelta…
-
Podcast: ePRO explained
Episode three of The Zelta Podcast series looks at the current state of play for ePRO in the clinical trials…
-
Health on the brink: Africa in the wake of US aid cuts – podcast
This podcast explores the implications for Africa’s public health systems and clinical trial infrastructure after significantly reduced US aid and…
-
How ICH E6 (R3) is changing clinical trials
The latest ICH E6 (R3) guidelines could transform how clinical studies are built and operated. The updated ICH E6 (R3)…
-
The unsustainability of clinical trials and need for transformative change
With pressures only intensifying on clinical trials, there are major concerns that current models are inefficient and unsustainable. Insight from…